1. Home
  2. KRYS vs COLD Comparison

KRYS vs COLD Comparison

Compare KRYS & COLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • COLD
  • Stock Information
  • Founded
  • KRYS 2015
  • COLD 1903
  • Country
  • KRYS United States
  • COLD United States
  • Employees
  • KRYS N/A
  • COLD N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • COLD Real Estate Investment Trusts
  • Sector
  • KRYS Health Care
  • COLD Real Estate
  • Exchange
  • KRYS Nasdaq
  • COLD Nasdaq
  • Market Cap
  • KRYS 4.3B
  • COLD 4.8B
  • IPO Year
  • KRYS 2017
  • COLD 2018
  • Fundamental
  • Price
  • KRYS $150.49
  • COLD $14.94
  • Analyst Decision
  • KRYS Strong Buy
  • COLD Buy
  • Analyst Count
  • KRYS 10
  • COLD 13
  • Target Price
  • KRYS $204.90
  • COLD $22.62
  • AVG Volume (30 Days)
  • KRYS 422.6K
  • COLD 4.0M
  • Earning Date
  • KRYS 08-04-2025
  • COLD 08-07-2025
  • Dividend Yield
  • KRYS N/A
  • COLD 6.15%
  • EPS Growth
  • KRYS 36.22
  • COLD N/A
  • EPS
  • KRYS 4.91
  • COLD N/A
  • Revenue
  • KRYS $359,205,000.00
  • COLD $2,616,917,000.00
  • Revenue This Year
  • KRYS $34.33
  • COLD N/A
  • Revenue Next Year
  • KRYS $47.84
  • COLD $3.87
  • P/E Ratio
  • KRYS $30.77
  • COLD N/A
  • Revenue Growth
  • KRYS 116.08
  • COLD N/A
  • 52 Week Low
  • KRYS $122.80
  • COLD $14.23
  • 52 Week High
  • KRYS $207.84
  • COLD $29.79
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 56.41
  • COLD 44.62
  • Support Level
  • KRYS $142.51
  • COLD $14.32
  • Resistance Level
  • KRYS $147.58
  • COLD $14.95
  • Average True Range (ATR)
  • KRYS 4.78
  • COLD 0.52
  • MACD
  • KRYS 0.39
  • COLD 0.00
  • Stochastic Oscillator
  • KRYS 92.81
  • COLD 31.84

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 239 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

Share on Social Networks: